SB
SwitchPoint Bio Holding, Inc.
SEC filingBiotechnology · Wilmington, DE
Amount raised$5.3Msold at filing
Total offering$5.3M
Investors in the raise6count reported to the SEC
FiledMar 10, 2026first sale Mar 9, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jussi PaananenExecutive Officer, Director
David ProctorDirector
Samuel MyllykangasExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.